Please use this identifier to cite or link to this item:
Title: Anti-tuberculosis host response modulation through immune cell targeting
Keywords: subunit vaccine tuberculosis DCs RGD Ag85B
Issue Date: 3-Feb-2009
Citation: SUN WEILING (2009-02-03). Anti-tuberculosis host response modulation through immune cell targeting. ScholarBank@NUS Repository.
Abstract: Development of a subunit tuberculosis vaccine based on a peptide from the immunogenic M. tuberculosis protein Ag85B was studied. Dendritic cells (DCs) are antigen-presenting cells that drive T cell responses in tuberculosis. The integrin-binding arginine-glysine-asparate (RGD) motif was included at the N-terminus of the Ag85B peptide for DC targeting. Immunological effects on bone-marrow differentiated DCs were compared between Ag85B and RGD-Ag85B peptides. RGD-Ag85B peptide was taken up more efficiently, processed by both major histocompatibility complex (MHC) class I and II pathways and induced a higher level of interleukin-12 production. In murine immunisation experiments, RGD-Ag85B was introduced subcutaneously, with a Th1-inducing adjuvant, after prior in vivo fms-like tyrosine kinase (Flt3) immunisation to expand the DC population. A relatively higher level of T cell proliferation, interleukin-2 and interferon-N3 production, as well as induction of antigen-specific T cells, was noted compared to unimmunised mice. This strategy may be a useful way of improving subunit vaccine immunogenicity.
Appears in Collections:Master's Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
SunWL.pdf807.26 kBAdobe PDF



Page view(s)

checked on Apr 20, 2019


checked on Apr 20, 2019

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.